Advances in Clinical Chemistry, Volume 119, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. Topics covered in this new release include Advances in Endotoxin Analysis, SARS-CoV-2 detection and surveillance, Osteopontin in Cancer, Gastrointestinal Hormones: History, Biology, and Measurement, Natriuretic Peptide Testing Strategies in Heart Failure: a 2023 Update, and Defining Allowable Total Error Limits in the Clinical Laboratory.
1. Advances in Endotoxin Analysis Palak Sondhi, Taiwo Adeniji, Dhanbir Lingden and Keith J. Stine 2. SARS-CoV-2 detection and surveillance Takayuki Ishige 3. Osteopontin in Cancer Alpana Kumari, Dharambir Kashyap and Vivek Kumar Garg 4. Gastrointestinal Hormones: History, Biology, and Measurement Jens F. Rehfeld and Jens P. Goetze 5. Natriuretic Peptide Testing Strategies in Heart Failure: a 2023 Update Thanat Chaikijurajai, Hernan Rincon Choles and W. H. Wilson Tang 6. Defining Allowable Total Error Limits in the Clinical Laboratory Jill Palmer and Kornelia Galior
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.